Page last updated: 2024-08-21

quinazolines and Opportunistic Infections

quinazolines has been researched along with Opportunistic Infections in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's0 (0.00)29.6817
2010's7 (70.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Einsele, H; Fuji, S; Kapp, M1
Meesing, A; Razonable, RR1
Andre, P; Asner, SA; Buclin, T; Decosterd, LA; Gengler, C; Jaton-Ogay, K; Mercier, T; Meylan, P; Murray, K; Natterer, J; Opota, O; Pérez Marín, M; Perez, MH; Rizzi, M1
Arns, W; Beelen, DW; Budde, K; Dürr, M; Fischereder, M; Gwinner, W; Hummel, J; Lischka, P; Michel, D; Mühlfeld, A; Renders, L; Rübsamen-Schaeff, H; Stangl, M; Stoelben, S; Suwelack, B; Witzke, O; Zimmermann, H1
Bornhäuser, M; Brown, J; Champlin, RE; Chemaly, RF; Ehninger, G; Einsele, H; Groth, C; Kölling, K; Lischka, P; Mullane, KM; Nowak, H; Richard, MP; Rübsamen-Schaeff, H; Silverman, M; Stobernack, HP; Stoelben, S; Ullmann, AJ; Zimmermann, H1
Emery, VC; Griffiths, PD1
Chemaly, RF; Ehninger, G; Ullmann, AJ1
DiPersio, JF; Romee, R1
Davey, RT; Masur, H1

Reviews

3 review(s) available for quinazolines and Opportunistic Infections

ArticleYear
Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options.
    Current opinion in infectious diseases, 2017, Volume: 30, Issue:4

    Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Forecasting; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Opportunistic Infections; Postoperative Complications; Quinazolines; Transplant Recipients

2017
Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation.
    Expert review of clinical pharmacology, 2018, Volume: 11, Issue:8

    Topics: Acetates; Antiviral Agents; Cytomegalovirus Infections; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Opportunistic Infections; Organ Transplantation; Quinazolines; Viral Load

2018
Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Humans; Opportunistic Infections; Pneumonia, Pneumocystis; Quinazolines; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate

1990

Trials

2 trial(s) available for quinazolines and Opportunistic Infections

ArticleYear
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.
    Transplant international : official journal of the European Society for Organ Transplantation, 2014, Volume: 27, Issue:1

    Topics: Acetates; Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Humans; Kidney Transplantation; Male; Middle Aged; Opportunistic Infections; Quinazolines; Viral Load; Viremia

2014
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation.
    The New England journal of medicine, 2014, May-08, Volume: 370, Issue:19

    Topics: Acetates; Adult; Antiviral Agents; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Double-Blind Method; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Kaplan-Meier Estimate; Opportunistic Infections; Quinazolines; Transplantation, Homologous; Treatment Failure

2014

Other Studies

5 other study(ies) available for quinazolines and Opportunistic Infections

ArticleYear
Compassionate Use of Letermovir in a 2-Year-Old Immunocompromised Child With Resistant Cytomegalovirus Disease.
    Journal of the Pediatric Infectious Diseases Society, 2020, Feb-28, Volume: 9, Issue:1

    Topics: Acetates; Antiviral Agents; Child, Preschool; Compassionate Use Trials; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Dose-Response Relationship, Drug; Drug Monitoring; Extracorporeal Membrane Oxygenation; Fatal Outcome; Female; Ganciclovir; Hepatitis, Viral, Human; Humans; Immunocompromised Host; Opportunistic Infections; Pneumonia, Viral; Polymerase Chain Reaction; Quinazolines; Treatment Failure; Viral Load

2020
Taming the transplantation troll by targeting terminase.
    The New England journal of medicine, 2014, May-08, Volume: 370, Issue:19

    Topics: Acetates; Antiviral Agents; Cytomegalovirus Infections; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Opportunistic Infections; Quinazolines

2014
CMV prophylaxis in hematopoietic-cell transplantation.
    The New England journal of medicine, 2014, 08-07, Volume: 371, Issue:6

    Topics: Acetates; Antiviral Agents; Cytomegalovirus Infections; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Opportunistic Infections; Quinazolines

2014
CMV prophylaxis in hematopoietic-cell transplantation.
    The New England journal of medicine, 2014, 08-07, Volume: 371, Issue:6

    Topics: Acetates; Antiviral Agents; Cytomegalovirus Infections; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Opportunistic Infections; Quinazolines

2014
[AIDS. Trimetrexate--alternative in Pneumocystis carinii pneumonia].
    Fortschritte der Medizin, 1988, Apr-20, Volume: 106, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Humans; Opportunistic Infections; Pneumonia, Pneumocystis; Quinazolines; Trimetrexate

1988